It's Down, It's Up

As world markets fluctuate, FierceBiotech writes that the biotech sector is a bit shaken. On Monday, the US stock market fell dramatically in the morning before rising again in the afternoon, with the New York Times noting that the decline likely stemmed from concerns regarding the slowing of the Chinese economy.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.